Safe tracking registry for people with Afib
Part of Heart & circulation clinical trials.
This registry is collecting health information from people with atrial fibrillation (Afib) who are being considered for a procedure to restore normal rhythm. It aims to better understand safety and outcomes so future care can be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Afib that comes and goes (paroxysmal) or lasts (persistent)
- Your doctor is planning catheter ablation and/or electrical cardioversion
- You can sign and give informed consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects data from heart imaging tests (TEE) in people with atrial fibrillation or atrial flutter. It aims to better understand how these imaging results relate to treatment decisions and outcomes.
This registry collects information on people with atrial fibrillation to understand how different treatments affect their health and quality of life over time.
This study tracks patients with atrial fibrillation (AF) over time to better understand the condition and improve care. You may be asked to share health information and attend follow-up visits.
This study observes people with atrial fibrillation or ventricular tachycardia who are having their first catheter ablation procedure. The goal is to collect information to improve future treatments.
This registry study follows people with atrial fibrillation to learn which risk factors are linked to stroke or blood clots traveling through the body. Your information helps improve how doctors predict risk and choose prevention strategies.
This study is a real-world registry that collects health information from people who have atrial fibrillation and were treated with a heart surgery procedure called ablation. It may help doctors better understand outcomes and care for people with this condition.
Hear when a new Atrial Fibrillation, Paroxysmal or Persistent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.